A Safety, Tolerability and Pharmacokinetic Study of CPP-115

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

August 31, 2012

Conditions
Cocaine Dependency
Interventions
DRUG

CPP-115

Appropriate amount of drug substance will be dissolved in juice within 3 hours of dosing.

DRUG

Placebo

An equal volume of water mixed with juice will be administered.

Trial Locations (1)

10019

Clinilabs, Inc., New York

Sponsors
All Listed Sponsors
lead

Catalyst Pharmaceuticals, Inc.

INDUSTRY

NCT01493596 - A Safety, Tolerability and Pharmacokinetic Study of CPP-115 | Biotech Hunter | Biotech Hunter